Chemed (NYSE:CHE) Releases FY 2025 Earnings Guidance

Chemed (NYSE:CHE) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 24.950-25.450 for the period, compared to the consensus estimate of 24.890. The company issued revenue guidance of -.

Chemed Price Performance

Chemed stock traded up $22.45 during midday trading on Thursday, hitting $568.24. 8,359 shares of the stock were exchanged, compared to its average volume of 89,309. The company has a 50 day moving average price of $543.86 and a two-hundred day moving average price of $563.11. The firm has a market cap of $8.55 billion, a P/E ratio of 29.38, a P/E/G ratio of 2.15 and a beta of 0.48. Chemed has a 1 year low of $512.12 and a 1 year high of $654.62.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.35%. Chemed’s dividend payout ratio (DPR) is 10.11%.

Analyst Upgrades and Downgrades

Several brokerages have commented on CHE. Royal Bank of Canada dropped their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a report on Saturday, November 30th.

Insiders Place Their Bets

In related news, VP Brian C. Judkins acquired 145 shares of the company’s stock in a transaction on Monday, December 30th. The shares were purchased at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now owns 1,678 shares in the company, valued at $871,721. This represents a 9.46 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 3.32% of the company’s stock.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.